RuiYi Inc., a San Diego-Shanghai biotech, signed an exclusive license with Genor BioPharma of Shanghai to develop RuiYi’s lead molecule in China; RuiYi also enlisted CMC Biologics to develop a cell... Read More
from ChinaBio® Today
WuXi PharmaTech released positive financial results for the first quarter of 2013, as revenues increased 11.7% to $132 million. All sectors of the company’s CRO/CMO business contributed to the climb.... Read More
from ChinaBio® Today
WuXi PharmaTech (WX) Tops Q1 EPS by 4c; Guides Q2
May 13, 2013
Earnings Scheduled For May 13, 2013
May 13, 2013
Trading Radar for 05/13: Take-Two Int. (TTWO), Stratasys (SSYS), InterOil (IOC), Velti (VELT) Report
May 10, 2013
Shanghai Fosun Pharma, Chindex and a private equity partner will spend $240 million to buy a 95.6% stake in Alma Lasers, an Israeli medical device company; Ascletis, a China-US drug developer,... Read More
from ChinaBio® Today
Syros Pharmaceuticals of Boston raised $30 million to develop cancer treatments from WuXi PharmaTech and other investors; a subsidiary of Hua Han Bio-Pharma signed a framework agreement to set up a JV... Read More
from ChinaBio® Today
Syros Pharmaceuticals, a Boston area startup, raised $30 million to develop treatments for cancer and other diseases by controlling the switches that regulate gene expression. The WuXi PharmaTech... Read More
from ChinaBio® Today
WuXi PharmaTech Cayman: 52-Week High Recently Eclipsed (WX)
March 26, 2013
Sinopharm Holdings, one of China’s big-three drug distributors, will issue $640 million of five-year corporate bonds that may be used to fund new acquisitions; Shanghai Fosun Pharma will buy $22.4... Read More
from ChinaBio® Today
WuXi PharmaTech Cayman: The Winning Streak Continues (WX)
March 08, 2013
WuXi PharmaTech Reports $500 Million in 2012 Revenues
March 08, 2013
WuXi PharmaTech reported another year of steadily increasing growth for 2012, something it seems to do with metronomic regularity. In 2012, the company’s net revenues rose 23% to just under $500... Read More
from ChinaBio® Today
Jefferies Lifts PT on WuXi PharmaTech (WX) to $21
March 08, 2013
Wuxi Pharmatech (WX) Approves $100M ADS Buyback
March 07, 2013
WuXi PharmaTech (WX) Tops Q4 EPS by 8c; Guides FY13
March 07, 2013
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here